<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03081286</url>
  </required_header>
  <id_info>
    <org_study_id>S-20160185</org_study_id>
    <nct_id>NCT03081286</nct_id>
  </id_info>
  <brief_title>Treatment of Postmastectomy Pain Syndrome With Fat Grafting</brief_title>
  <official_title>Treatment of Postmastectomy Pain Syndrome With Fat Grafting: A Double-blinded Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the possible beneficial effect of fat grafting for post mastectomy pain
      syndrome. Half of patients will receive fat grafting and the other half of patients will
      receive sham.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have suggested that fat grafting can alleviate pain in post mastectomy pain
      syndrome. These studies however have either been in the form of case series or unblinded
      studies with great risk of bias.

      It is believed that fat grafting with its content of adipose-derived stem cells can modulate
      the scar tissue upon grafting and hereby decrease pain.

      In this study patients will be randomized to either fat grafting or a sham procedure where
      they undergo the same liposuction but no fat grafting, only injection of saline instead of
      fat.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>During general anesthesia, patients are randomized to either fat grafting or sham grafting with only saline. All patients undergo the same liposuction. Participants are blinded, care providers postoperatively are blinded. The surgeon performing the procedure is not blinded. The outcome assessors 3 and 6 months postoperatively are blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain on visual analog scale (VAS) 0-10</measure>
    <time_frame>6 months</time_frame>
    <description>Pain on visual analog scale (VAS) 0-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropathic Pain Symptom Inventory</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of pain medication</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>pain medication used is registered on questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain on visual analog scale (VAS) 0-10</measure>
    <time_frame>3 months</time_frame>
    <description>Pain on visual analog scale (VAS) 0-10</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Complications</measure>
    <time_frame>3 months</time_frame>
    <description>Any complications following treatment</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Post-Mastectomy Chronic Pain Syndrome (Disorder)</condition>
  <arm_group>
    <arm_group_label>Fat grafting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following liposuction the fat is decanted and used for fat grafting to the area of pain after breast cancer surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham grafting</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Following liposuction the fat is discarded. Instead approximately 50mL of saline is used instead of fat and injected into the area of pain after breast cancer surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Liposuction</intervention_name>
    <description>Liposuction is performed on the abdomen or thighs as determined before randomization by the surgeon.</description>
    <arm_group_label>Fat grafting</arm_group_label>
    <arm_group_label>Sham grafting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fat graft</intervention_name>
    <description>The harvested lipoaspirate is injected at the site of pain.</description>
    <arm_group_label>Fat grafting</arm_group_label>
    <other_name>lipotransfer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham graft (saline injection)</intervention_name>
    <description>Saline will be injected at the site of pain instead of fat</description>
    <arm_group_label>Sham grafting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Treated for breast cancer

          -  Pain in the breast cancer treated area on the breast or axilla.

          -  Pain present at least 4 days a week with an intensity above 3 on VAS.

          -  Duration longer than 3 months

          -  Recurrence free for minimum 6 months

          -  Understand the nature of the study and can give informed consent

        Exclusion Criteria:

          -  Psychiatric condition that can affect participation.

          -  Recurrence of breast cancer at any time.

          -  Other indication for fat grafting other than pain treatment.

          -  Breast reconstruction with flap
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens A SÃ¸rensen, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2017</study_first_submitted>
  <study_first_submitted_qc>March 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2017</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Martin Sollie</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

